Cart
sales@molnova.com
Mefloquine
CAS No. 53230-10-7
Mefloquine ( Lariam; Ro 215998; Ro-215998; Ro215998; WR 142490 )
Catalog No. M26006 CAS No. 53230-10-7
Mefloquine, a quinoline antimalarial agent, is an anti-SARS-CoV-2 entry inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 302 | In Stock |
|
| 10MG | 447 | In Stock |
|
| 25MG | 714 | In Stock |
|
| 50MG | 1017 | In Stock |
|
| 100MG | 1368 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameMefloquine
-
NoteResearch use only, not for human use.
-
Brief DescriptionMefloquine, a quinoline antimalarial agent, is an anti-SARS-CoV-2 entry inhibitor.
-
DescriptionMefloquine, a quinoline antimalarial agent, is an anti-SARS-CoV-2 entry inhibitor. Mefloquine is also a K+ channel (KvQT1/minK) antagonist with an IC50 of ~1 μM. Mefloquine can be used for malaria, systemic lupus erythematosus, and cancer research.
-
SynonymsLariam; Ro 215998; Ro-215998; Ro215998; WR 142490
-
PathwayOthers
-
TargetOther Targets
-
RecptorBacterial
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number53230-10-7
-
Formula Weight378.3
-
Molecular FormulaC17H16F6N2O
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO[C@H]([C@H]1CCCCN1)c1cc(nc2c(cccc12)C(F)(F)F)C(F)(F)F
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Isolation, identification and antimicrobial activity of ombuoside from Stevia triflora.Ann Pharm Fr. 1997;55(6):262-8.
molnova catalog
related products
-
Spautin-1
Spautin-1 is a bioactive chemical.
-
[D-p-Cl-Phe6,Leu17]-...
Selective vasoactive intestinal peptide (VIP) receptor antagonist (IC50 = 125.8 nM). Displays no activity on glucagon, secretin or GRF receptors.
-
PK68
PK68 is an effective and selective inhibitor of type II receptor-interacting kinase 1 (RIPK1, IC50 = 90?nM). PK68 can be used for research on the treatment of inflammatory disorders and cancer metastasis.
